Drug to prevent exercise-induced arrhythmias identifiedMarch 30th, 2009 - 5:56 pm ICT by ANI
London, Mar 30 (ANI): Vanderbilt University Medical Center researchers have found that a drug can prevent potentially lethal arrhythmias caused due to exercise or stress, called CPVT.
Patients with CPVT experience abnormally rapid heart rates (tachycardia), usually during exercise or stress, and are at risk for fainting and cardiac arrest.
“It’s potentially a breakthrough in the treatment of this rare syndrome,” Nature quoted Bjorn Knollmann, M.D., Ph.D., associate professor of Medicine and Pharmacology, as saying.
For a long time, researchers have been studying the molecular defects that trigger arrhythmias and knew that the disorder is caused by mutations in two genes that encode calcium-handling proteins- the ryanodine receptor and calsequestrin.
In 2006, the group discovered these mutations allows calcium to “leak” out of its storage containers inside heart cells and cause arrhythmias at the cellular level.
The researchers developed a mouse model for CPVT (by eliminating the calsequestrin gene) and proposed using the model to study medications and interventions for the disorder.
When they tried flecainide, a clinically available anti-arrhythmic that is used to treat atrial fibrillation, it gave positive results.
In isolated heart cells, flecainide blocked the ryanodine receptor and the calcium “leak” (the underlying molecular defect in CPVT), and it completely prevented ventricular arrhythmias in the mouse model of CPVT.
“So we knew that this established drug specifically targets the disease mechanism in CPVT,” said Knollmann.
They then tested the drug in two patients, and found that, flecainide (combined with a beta blocker in the boy) prevented exercise-induced ventricular arrhythmias in both patients.
The patients have taken flecainide for more than six months now and are living normal lives.
The study was published in Nature Medicine. (ANI)
- Deadly heart disease treatable with old drug - Apr 03, 2009
- Common drugs can cause abnormal heart beats - Jan 31, 2011
- Critical enzyme in healthy heart function identified - Feb 20, 2010
- Potential genetic target for heart disease discovered - Nov 18, 2010
- Potential treatment target for congenital heart disease identified - Feb 22, 2011
- One in 25 Indians carries gene that triggers heart failure - Jun 10, 2010
- 1 in 25 people from India carries a gene mutation that causes heart failure - Jun 09, 2010
- New approach could reverse liver failure - Aug 06, 2012
- New ways for heart treatment - Mar 11, 2010
- Bodily symptoms of anxiety may make a difference in treatment - Oct 25, 2010
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Study uncovers DNA sequence variations that make the heart beat - Nov 15, 2010
- Epilepsy trigger found - Mar 19, 2011
- How a gene mutation leads to autism - Dec 17, 2010
- Cholesterol busting drugs might be bad for you - Dec 21, 2010
Tags: beta blocker, cardiac arrest, cellular level, center researchers, cpvt, disease mechanism, fibrillation, heart cells, heart rates, lethal arrhythmias, mouse model, nature medicine, rapid heart, rare syndrome, ryanodine receptor, storage containers, time researchers, university medical center, vanderbilt university medical, vanderbilt university medical center